Michael A Wolfson, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 627 Bradford Pkwy, Syracuse, NY 13224 Phone: 315-449-1707 |
Ivan L Wolf, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 961 Canal Street, Syracuse, NY 13210 Phone: 315-478-1977 Fax: 315-475-2909 |
Dr. Reza Hosseini, MD Preventive Medicine - Occupational Medicine Medicare: Medicare Enrolled Practice Location: 6712 Brooklawn Pkwy, Ste 204, Syracuse, NY 13211 Phone: 315-432-8899 Fax: 315-431-9528 |
Dr. Joseph Monkofsky Jr., M.D.,M.P.H. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 5092 Bradbury Dr, Syracuse, NY 13215 Phone: 315-440-8970 Fax: 315-492-3585 |
Michael B. Lax, MD Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 Irving Ave, Suite 200, Syracuse, NY 13210 Phone: 315-464-4686 Fax: 315-464-7106 |
News Archive
Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, announced today that substantially all of the assets of its subsidiary, Acoustic Marketing Research, Inc., DBA Sonora Medical Systems, were sold to Medical Imaging Holdings, Inc., for $8 million in cash.
IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group.
It is common for patients initially diagnosed with lung cancer to have the cancer spread to sites like the liver, brain and bone. One of the most frequent sites of metastases is the bone, with an estimated 30 to 40 percent of patients with non-small-cell lung cancer (NSCLC) developing bone loss.
Intravenous low molecular weight iron dextran appears to provide effective long-lasting treatment for some patients with restless leg syndrome, even for those with normal serum ferritin levels, research indicates.
Responding to the launch of the Scottish Executive's public consultation on smoking in public places, Dr Bill O'Neill, Scottish Secretary of the BMA said: "I am pleased that the Scottish Executive has finally succumbed to public pressure and launched a consultation into the creation of more smoke free public areas.
› Verified 4 days ago